Protect B12!

One June 9th, 2021, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) will meet to discuss whether traditional compounding pharmacies will be permitted to make medicines with methylcobalamin, choline chloride, and melatonin, among others. That compounded methylcobalamin, a bioavailable form of vitamin B12, is on the chopping block is particularly concerning, as it has shown promise in the treatment of autism and other health problems. We must speak out so the FDA knows that consumers rely on these vital medicines.

Write to the FDA and PCAC, urging them to preserve access to these important compounded supplements.

Recipients

  • Food and Drug Administration
  • Pharmacy Compounding Advisory Committee

Contact

*Required fields
 
 

Message

Please preserve access to methylcobalamin

Dear [Decision Maker],

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]